Prevalence and Incidence of Adrenomyodystrophy
Adrenomyodystrophy: Rare Disease
Adrenomyodystrophy is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Adrenomyodystrophy, or a subtype of Adrenomyodystrophy,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Adrenomyodystrophy as a "rare disease".
More information about Adrenomyodystrophy is available from Orphanet
About prevalence and incidence statistics:
The term 'prevalence' of Adrenomyodystrophy usually refers to the estimated population
of people who are managing Adrenomyodystrophy at any given time.
The term 'incidence' of Adrenomyodystrophy refers to the annual diagnosis rate,
or the number of new cases of Adrenomyodystrophy diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.